0
Onconova Therapeutics, Inc. Banner Image

Onconova Therapeutics, Inc.

  • Ticker ONTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Onconova Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Newtown, Pennsylvania
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.
Onconova Therapeutics, Inc.

Most Recent Annual Report

Onconova Therapeutics, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Onconova Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports